Pulmonx Corp - COM (LUNG)

Historical Holders from Q4 2020 to Q3 2025

Symbol
LUNG on Nasdaq
CUSIP
745848101
Type / Class
Equity / COM
Shares outstanding
40.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.8M
Holdings value
$51.5M
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
102
Number of buys
49
Number of sells
-55
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Pulmonx Corp - COM (LUNG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRIMECAP MANAGEMENT CO/CA/ 12.16% -10.4% $8.03M -$742K 4.96M -8.46% PRIMECAP MANAGEMENT CO/CA/ Sep 30, 2025
MORGAN STANLEY 8.5% +12.5% $17.5M $2.2M 3.39M +14.4% Morgan Stanley Mar 31, 2025
BlackRock, Inc. 6.8% $13.9M 2.69M BlackRock, Inc. Mar 31, 2025
FMR LLC 0.2% -104% $115K -$3.42M 70.8K -96.8% FMR LLC Oct 31, 2025

Institutional Holders of Pulmonx Corp - COM (LUNG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.8M $51.5M -$11.7M $1.62 102
2025 Q2 36.3M $93.9M -$4.6M $2.59 113
2025 Q1 36.2M $243M +$1.66M $6.73 114
2024 Q4 35.9M $244M +$2.67M $6.79 117
2024 Q3 35.4M $293M +$6.9M $8.29 112
2024 Q2 34.7M $220M -$1.07M $6.34 108
2024 Q1 34.5M $320M +$4.89M $9.27 116
2023 Q4 33.5M $427M +$23.8M $12.75 122
2023 Q3 32.9M $340M -$11.6M $10.33 112
2023 Q2 33.9M $444M -$9.64M $13.11 112
2023 Q1 34.7M $388M +$25.5M $11.18 106
2022 Q4 33.8M $285M -$83.1M $8.43 110
2022 Q3 34.9M $581M -$4.92M $16.66 99
2022 Q2 35.3M $520M -$7.9M $14.72 102
2022 Q1 34.7M $861M +$56.9M $24.81 105
2021 Q4 32M $1.03B +$25.9M $32.07 110
2021 Q3 31.6M $1.14B +$204M $35.98 120
2021 Q2 25.8M $1.14B +$216M $44.12 115
2021 Q1 20.8M $951M +$116M $45.74 108
2020 Q4 17.3M $1.18B +$1.02B $69.02 98